薬事申請における安全性試験と動物福祉
スポンサーリンク
概要
- 論文の詳細を見る
In the Pharmaceuticals Affairs Law, development, manufacturing and marketing of drugs, quasi-drugs, cosmetics and medical devices are regulated from the point of view of their quality, efficacy and safety. Non-clinical safety data are required not only to consider relationship between test substances and adverse events occurred in clinical trials at review of the application but also to evaluate safety and ethical appropriateness of protocols of clinical trials during development of them. Alternative tests to animal testing are quite important in the regulation of drugs, quasi-drugs and cosmetics from two viewpoints: one is the animal welfare, and the other is the sufficient evaluation of safety of products. From the administrative point of view, objectives and usages of results of alternative tests for drugs, quasi-drugs and cosmetics should be considered on development, evaluation and validation of alternative tests.
- 日本環境変異原学会の論文
日本環境変異原学会 | 論文
- P-145 化学物質の変異原性に関するEU分類とドイツMAK分類の比較(ポスターセッション)
- P144 生殖細胞変異原のGHS分類基準適用における問題点
- P-98 GHSにおける生殖細胞変異原性物質の分類(ポスター(2))
- リスクアセスメントにおける遺伝毒性 : 海外の動向と視点(第33回大会シンポジウム1「発がん性と遺伝毒性の閾値 : リスクアセスメントにおける問題点」)
- S2-4 環境汚染物質による野生生物のリスクを評価するための科学的方法(シンポジウム2:「環境と食の安全性にサイエンスが果たす役割」)